Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA: 688266)
China
· Delayed Price · Currency is CNY 61.58
+0.50 (0.82%)
Jan 3, 2025, 3:00 PM CST
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. Market Cap
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. has a market cap or net worth of 16.30 billion as of January 3, 2025. Its market cap has increased by 21.75% in one year.
Market Cap
16.30B
Enterprise Value
15.02B
Revenue
488.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.58
Market Cap Chart
Since January 23, 2020, Suzhou Zelgen Biopharmaceuticals Co.,Ltd.'s market cap has decreased from 17.90B to 16.30B, a decrease of -8.94%. That is a compound annual growth rate of -1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 16.30B | -1.17% |
| Dec 31, 2024 | 16.49B | 17.70% |
| Dec 29, 2023 | 14.01B | 40.02% |
| Dec 30, 2022 | 10.01B | -29.08% |
| Dec 31, 2021 | 14.11B | -9.10% |
| Dec 31, 2020 | 15.53B | -13.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Mindray Bio-Medical Electronics | 294.68B |
| Jiangsu Hengrui Medicine | 282.07B |
| WuXi AppTec | 150.20B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.98B |
| Aier Eye Hospital Group | 116.12B |
| Shanghai United Imaging Healthcare | 103.88B |
| Yunnan Baiyao Group Co.,Ltd | 103.36B |
| Beijing Wantai Biological Pharmacy Enterprise | 89.42B |